comparemela.com
2
3
4
5
6
7
8
Latest Breaking News On - Pertuzumab - Page 1 : comparemela.com
Trastuzumab Plus Pertuzumab Provides Sustained iDFS Benefit in HER2+ Breast Cancer
A chemotherapy-free regimen of trastuzumab plus pertuzumab generated a strong 3-year iDFS rate in patients with HER2-positive early breast cancer.
Valencia
Carabobo
Venezuela
Spain
Antonio-llombart-cussac
University-hospital-arnau-de-vilanova
Oncology-service
Medical-oncology-service
Her2-positive-early-breast-cancer
Chemotherapy-free-regimen
Btrastuzumab
Pertuzumab
NRG-GY018 and RUBY Trials in Endometrial Cancer
Experts on endometrial cancer review the NRG-GY018 and RUBY clinical trials.
Ramez-eskander
Matthewa-powell
Ursulaa-matulonis
Bhavana-pothuri
Shannonn-westin
Endometrial-cancer
Ruby-trial
Asco-2023
Nrg-gy018
Sgo-2023
Pembrolizumab
Ongoing Research in HER2+ Metastatic Breast Cancer
An overview of agents and treatment strategies currently being investigated in HER2+ metastatic breast cancer.
Megan-kruse
Her2-metastatic-breast-cancer
Precious-trial
Pertuzumab
Taxane
Btrastuzumab
T-dm1
Overall-survival
Asco-2023
Her2-targeted-therapy
Leptomeningeal-disease
Patient Profile: A 68-Year-Old Woman With HER2+ Metastatic Breast Cancer
Expert oncologist Virginia Kaklamani, MD, DSc, shares her perspectives on a patient case of HER2+ metastatic breast cancer (mBC) treated with multiple lines of therapy.
Improving-outcomes
Breast-cancer
Translating-evidence
Clinical-practice
Year-old-woman-with
Metastatic-breast-cancer
Virginia-kaklamani
Her2-positive
Her2-breast-cancer
Ild
Interstitial-lung-disease
Overview of the HER2+ Metastatic Breast Cancer Treatment Armamentarium
A key opinion leader in breast cancer management shares insight on the treatment armamentarium for patients with HER2+ disease.
Improving-outcomes
Breast-cancer
Translating-evidence
Clinical-practice
Metastatic-breast-cancer-treatment
Metastatic-breast-cancer
Her2-positive
Her2-breast-cancer
Thp-therapy
Btrastuzumab
Pertuzumab
vimarsana © 2020. All Rights Reserved.